Fluorescence quenching studies with proteins

doi:10.1016/0003-2697(81)90474-7

Analytical Biochemistry

Volume 114, Issue 2, 1 July 1981, Pages 199-227

https://doi.org/10.1016/0003-2697(81)90474-7 Get rights and content

Abstract

A review is presented on the use of the technique of solute fluorescence quenching to study the structure and dynamics of proteins. A number of factors are discussed that must be considered in analyzing such data. Among these factors are the efficiency of the quenching process, the relative importance of static quenching, the heterogeneity of the emission, and the tendency of the quencher to interact with the protein.

References (98)

S.S. Lehrer et al.
J.C. Andre et al.
Chem. Phys
(1978)
J.C. Andre et al.
Chem. Phys
(1979)
J.P. Privat et al.
Biophys. Chem
(1980)
A. Grinvald et al.
Biochim. Biophys. Acta
(1976)
N.J. Turro et al.
Chem. Phys. Lett
(1979)
M.R. Eftink et al.
Biochim. Biophys. Acta
(1977)
W.L. Peticolas
C.K. Woodward et al.
J. Biol. Chem
(1975)
R.B. Visscher et al.
J. Biol. Chem
(1975)

R. Chen

Arch. Biochem. Biophys

(1973)

J.R. Lakowicz

J. Biochem. Biophys. Methods

(1980)

P. Wahl et al.

J. Mol. Biol

(1967)

M.J.E. Sternberg et al.

J. Mol. Biol

(1979)

K.R. Thulborn et al.

Biochim. Biophys. Acta

(1978)

J.R. Lakowicz et al.

Biochim. Biophys. Acta

(1977)

P. Cavatorta et al.

Biochim. Biophys. Acta

(1979)

V.G. Bieri et al.

Biochim. Biophys. Acta

(1975)

L. Brand et al.

J. Biol. Chem

(1971)

A. Gafni et al.

Biophys. J

(1977)

J.A. McCammon et al.

Nature (London)

(1977)

T. Komiyama et al.

J. Biochem

(1980)

N.E. Geacintov et al.

Biochem. Biophys. Res. Commun

(1975)

K. Imakubo

D.M. Rayner et al.

Canad. J. Chem

(1978)

I. Munro et al.

A. Weller

Progr. React. Kinet

(1961)

B.F. Peterman et al.

Arch. Biochem. Biophys

(1980)

C.F. Meares et al.

Biophys. J

(1981)

T. Ando et al.

J. Biochem

(1980)

S.S. Lehrer

I.M. Frank et al.

Z. Phys

(1931)

H. Boaz et al.

J. Amer. Chem. Soc

(1950)

E.J. Bowen et al.

W.R. Ware et al.

J. Phys. Chem

(1966)

J.L. Nemzek et al.

J. Chem. Phys

(1975)

E.A. Burstein

Biofizika

(1968)

A.Y. Moon et al.

J. Phys. Chem

(1965)

J.R. Lakowicz et al.

Biochemistry

(1973)

M.R. Eftink et al.

J. Phys. Chem

(1976)

W.M. Vaughn et al.

Biochemistry

(1970)

P.M. Froehlich et al.

Photochem. Photobiol

(1977)

R. Fenichel et al.

Ann. N. Y. Acad. Sci

(1965)

A.H. Alwattar et al.

M.R. Eftink et al.

Biochemistry

(1976)

S.S. Lehrer

Biochemistry

(1971)

T.C. Werner et al.

Photochem. Photobiol

(1979)

A.G. Szabo et al.

J. Amer. Chem. Soc

(1980)

M.R. Eftink et al.

Photochem. Photobiol

(1981)

J.R. Lakowicz et al.

Biochemistry

(1973)

Cited by (1708)

Exploring the molecular basis of tucatinib interaction with human serum albumin: A spectroscopic and computational analysis
2024, Journal of Molecular Liquids
This study delves into the kinetics of interaction among anticancer drug tucatinib (TCT) and human serum albumin (HSA), a pivotal protein that transports substances in the bloodstream of humans. Employing biophysical techniques alongside in-silico approaches, the TCT-HSA complex formation is substantiated. This binding interaction is unequivocally confirmed by the inverse relationship between temperature and Stern-Volmer constant (K_SV) and the hyperchromicity in UV–visible spectra. The binding constant (K_b) value (5.34 x 10⁴ M⁻¹) indicates a moderate affinity between TCT and HSA, with thermodynamic analysis pointing towards stabilization through hydrogen bonds and hydrophobic and van der Waals interactions. Moreover, despite causing alterations in the vicinity of Tyr and Trp amino acids, the introduction of TCT to HSA confers a substantial protective effect against the thermal denaturation of the protein. Circular dichroism unveils a decrease in the content of alpha helices upon TCT binding. At the same time, CD thermal analysis hints at a marginal increase in the melting temperature of HSA, indicating heightened stability at elevated temperatures. Molecular docking and competitive displacement assays confirm that the preferred binding site for TCT is subdomain IIA (Sudlow's site I) of HSA. Molecular dynamics simulations emphasize the stability of the TCT-HSA complex. This work sheds light on a detailed characterization of the HSA-TCT interaction, elucidating binding mechanisms and their consequential impact on HSA structure and stability.
Fluorescence study of the interaction between albumin and layered double hydroxides
2024, Chemico-Biological Interactions
Layered double hydroxides nanoparticles (LDH-NP) are increasingly studied for biomedical applications. Nevertheless, their interaction with biomolecules such as proteins needs further exploration for an effective application. In this work, the adsorption of bovine serum albumin (BSA) on LDH-NP and the conformation changes of the protein upon adsorption were characterized using fluorescence spectroscopy. First, the quenching of tryptophan residues of BSA by chloride-intercalated LDH-NP was explored and the BSA adsorption capacity of LDH-NP were determined. Then, the structural conformation of the protein was analyzed by fluorescence spectroscopy (including synchronous, polarization and quenching studies) at different surface coverages. Finally, the proclivity of adsorbed BSA molecules to assemble as amyloid fibril was evaluated. Due to the positive charging and low curvature of LDH-NP, BSA molecules were strongly adsorbed, which produced a quenching of the protein fluorescence and a large adsorption capacity. The effect on BSA conformation was dependent on surface coverage (SC): at low values $, t$ he tryptophan residues were in more hydrophobic environments and more accessible to quenchers than al high ones. At low SC, there is space between the BSA molecules to spread on the surface, which led to a conformation change. Contrarily, the native conformation around tryptophan residues of BSA was preserved at high SC due to the tight packing of the adsorbed protein molecules. As a result, BSA molecules are stabilized against the formation of amyloid fibrils at high $SC$ , while at low SC they present a similar fibrillation than free BSA.
Identification and characterization of repurposed small molecule inhibitors of Mycobacterium tuberculosis caseinolytic protease B (ClpB) as anti-mycobacterials
2024, International Journal of Biological Macromolecules
Mycobacterium tuberculosis (Mtb) caseinolytic protease B (ClpB) is a chaperone possessing a unique ability to resolubilize the aggregated proteins in vivo. ClpB has been shown to be important for the survival of Mtb within the host. Thus, it appears to be a promising target to develop new therapeutic molecules against tuberculosis. In this study, we have screened FDA approved compounds in silico to identify inhibitors against Mtb ClpB. In our screen, several compounds interacted with ClpB. The top four compounds, namely framycetin, gentamicin, ribostamycin and tobramycin showing the highest binding energy were selected for further investigation. MD simulations and tryptophan-based quenching of ClpB-drug complexes established that the selected inhibitors stably interacted with the target protein. The inhibitor and protein complexes were found to be stabilized by hydrogen bonding, and hydrophobic interactions. Although, the compounds did not affect the ATPase activity of ClpB significantly, the protein resolubilization activity of ClpB was remarkably reduced in their presence. All four compounds potently inhibited the growth of Mtb H37Ra. The antimycobacterial activity of the compounds appears to be due the inhibition of functional ClpB oligomer formation, in turn affecting its chaperonic activity.
The effect of membrane composition on the interaction between human CYP51 and its flavonoid inhibitor - luteolin 7,3′-disulfate
2024, Biochimica et Biophysica Acta - Biomembranes
Cytochromes P450 (CYP) are a family of membrane proteins involved in the production of endogenous molecules and the metabolism of xenobiotics. It is well-known that the composition of the membrane can influence the activity and orientation of CYP proteins. However, little is known about how membrane composition affects the ligand binding properties of CYP. In this study, we utilized surface plasmon resonance and fluorescence lifetime analysis to examine the impact of membrane micro-environment composition on the interaction between human microsomal CYP51 (CYP51A1) and its inhibitor, luteolin 7,3′-disulphate (LDS). We observed that membranes containing cholesterol or sphingomyelin exhibited the lowest apparent equilibrium dissociation constant for the CYP51A1-LDS complex. Additionally, the tendency for relation between kinetic parameters of the CYP51A1-LDS complex and membrane viscosity and overall charge was observed. These findings suggest that the specific composition of the membrane, particularly the presence of cholesterol and sphingomyelin, plays a vital role in regulating the interaction between CYP enzymes and their ligands.
Triplet state spectroscopy reveals involvement of the buried tryptophan residue 310 in Glyceraldehyde-3-phosphate dehydrogenase (GAPD) in the interaction with acrylamide
2024, Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy
Using conventional steady state and time resolved fluorescence study of the interaction between a multi-tryptophan protein and a quencher, it is difficult, if not impossible to identify the particular tryptophan residue/residues involved in the interaction. In this work we have exemplified the above contention using a multi-tryptophan protein, Glyceraldehyde-3-phosphate dehydrogenase (GAPD) from rabbit muscle having three tryptophan (Trp) residues at positions 84, 193 and 310 and a neutral quencher acrylamide in Tris buffer of pH 7.5. From the steady state and time resolved fluorescence quenching (at 298 K) with acrylamide K_sv, K and k_q for the system have been calculated. Low temperature phosphorescence (LTP) spectra at 77 K of GAPD in suitable cryosolvent is known to exhibit two (0,0) bands corresponding to two tryptophan residues 193 and 310. Using the LTP study of free GAPD and GAPD – acrylamide it is possible to identify that the buried Trp 310 residue is specifically involved in the interaction with acrylamide. This is possible without doing any site-directed mutagenesis of GAPD which contains Trp residues at 84, 193 and 310. Tyrosine 320 is also specifically quenched. The results have been corroborated using the molecular docking studies. Molecular Dynamics simulation supports our contention of the involvement of Trp 310 and also shows that the other nearest residues of acrylamide are Val175 and Val232.
Tracking the binding site of anticancer drug fluxoridin with Fe-related proteins to achieve intelligent drug delivery
2024, Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy
In cancer cells that need a lot of iron for growth and metastasis, halo-transferrin (TF-containing iron) enters the cell with the help of the transferrin receptor 1 (TFR1) protein. If the anticancer drug can bind to the iron site by interacting with apo-transferrin (iron-free FT), it can enter the cancer cell by the same mechanism. Two iron-related proteins, Bovine liver catalase (BLC) and apo-Transferrin (TF), that are important in cancer patients were selected and their interaction with the anti-cancer drug Floxuridine (FUDR) was investigated. Here, the protective role of FUDR was evaluated by several variables such as drug concentration, interaction time, and temperature-induced degradation of enzyme function. The results showed that the protective effect of the FUDR is greater in high concentrations (in 5 × 10^-5 M:1.78 % and 2.59 % after 24 and 48 h). The interaction of the FUDR with both proteins can reduce the intensity of the fluorescence emission by a static mechanism. The binding strength of the FUDR with both proteins was almost similar and with the order of 10⁴ M⁻¹ (K_b = 3.90 ± 0.41 × 10⁴ M⁻¹ for BLC-FUDR and 5.01 ± 0.36 × 10⁴ M⁻¹ for TF-FUDR at 310 K). The thermodynamic calculations (in agreement with the docking results) indicated that FUDR-protein complex formation was exothermic and the main binding forces in the binding process were van der Waals interactions and hydrogen bonds. Both fluorophores tryptophan (Trp) and tyrosine (Tyr) of both proteins had significant roles in fluorescence quenching and the interaction process, the polarity of their microenvironment changed. CD results showed that the secondary structure changes of TF are slightly more than BLC. Molecular docking showed that the binding of the FUDR to TF is very close to the Fe-specific site and is placed in the cavity among the wrapping domain, N-Terminal arm, and β-barrel in BLC.

View all citing articles on Scopus

View full text

ReviewFluorescence quenching studies with proteins

Abstract

Chem. Phys

Chem. Phys

Biophys. Chem

Biochim. Biophys. Acta

Chem. Phys. Lett

Biochim. Biophys. Acta

J. Biol. Chem

J. Biol. Chem

Arch. Biochem. Biophys

J. Biochem. Biophys. Methods

J. Mol. Biol

J. Mol. Biol

Biochim. Biophys. Acta

Biochim. Biophys. Acta

Biochim. Biophys. Acta

Biochim. Biophys. Acta

J. Biol. Chem

Biophys. J

Nature (London)

J. Biochem

Biochem. Biophys. Res. Commun

Canad. J. Chem

Progr. React. Kinet

Arch. Biochem. Biophys

Biophys. J

J. Biochem

Z. Phys

J. Amer. Chem. Soc

J. Phys. Chem

J. Chem. Phys

Biofizika

J. Phys. Chem

Biochemistry

J. Phys. Chem

Biochemistry

Photochem. Photobiol

Ann. N. Y. Acad. Sci

Biochemistry

Biochemistry

Photochem. Photobiol

J. Amer. Chem. Soc

Photochem. Photobiol

Biochemistry

Review
Fluorescence quenching studies with proteins